Warrant Grant. The Company hereby grants to the Warrantee a warrant (the “Warrant”) to purchase 5,000 shares (“Warrant Shares”, with each being a “Warrant Share”) of its $0.01 par value common stock (“Share”), under the terms and conditions set forth below.
Warrant Grant. Executive shall be issued 2,000,000 cashless warrants to acquire such number of shares of the Company’s common stock, as of October 1, 2012. The warrants in the amount of 1,000,000 immediately on the date of grant. The balance will vest in the amount of 250,000 at the end of each calendar quarter. The warrants will be fully vested on September 30, 2013. The warrants will expire on September 30, 2017.
Warrant Grant. FOR VALUE RECEIVED, the Company hereby certifies and agrees that upon the earlier of the Maturity Date or the date of any prepayment (a “Prepayment Date”) of the Loan, the Holder shall be entitled to purchase from the Company up to a four percent (4%) membership interest in the Company (the “Warrant Interest”) in exchange for the waiver, or partial waiver, of the payment of the Exit Fee in cash. In the event that the Fair Market Value of the Warrant Interest (as defined below) is less than the Exit Fee, or any portion of the Exit Fee, waived by the Company pursuant to any exercise hereof, the Company shall pay the difference between the amount of the Exit Fee, or portion thereof, waived in order to exercise this Warrant, and the aggregate portion of the Exit Fee that otherwise would have been due as of the date of the issuance of the Warrant Interest, or any portion thereof pursuant to exercise of this Warrant, to Holder in cash in accordance with Section 2.5 of the Loan Agreement. The Holder may exercise such right as of the Maturity Date or any Prepayment Date, in accordance with Section 3 hereof.
Warrant Grant. On the Effective Date of this Agreement, Archemix will grant to Isis a seven-year warrant to acquire 600,000 shares of Archemix’s common stock at a purchase price of twenty-five cents ($0.25) per share (subject to adjustment in the event of a stock split, reverse stock split or other similar events), by executing the warrant attached hereto as Appendix 5 (the “Warrant”). Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act.
Warrant Grant as additional consideration for extending the License Agreement to cover promotional products, Harbrew is hereby issuing to Seven Cellos a warrant to purchase 20,000 shares of the issued and outstanding stock of Company, for an exercise price equal to the lower of $1.00 per share, or 85% of the 30 day average bid and ask price as reported by the PinkSheets, OTC Bulletin Board or whatever exchange or service that lists the Company’s Common Stock; provided, however, that in no event shall the exercise price be less than $0.50 per share. Xxxxx Xxxx “Xxxx” shall also be granted a warrant to purchase 5,000 shares of the issued and outstanding stock of Company, for an exercise price of the lower of $1.00 per share, or 85% of the 30 day average bid and ask price as recorded on the PinkSheets, OTC Bulletin Board or whatever exchange or service that lists the Company’s Common Stock; provided, however, that in no event shall the exercise price be less than $0.50 per share.
Warrant Grant. (a) The Company hereby grants the Warrant Holder the right (such right, the Warrant Right) to acquire, upon delivery by the Warrant Holder of the Exercise Notice in accordance with Section 3, 1,675,885 Class B Shares (such Class B Shares, subject to the adjustments pursuant to the terms of Section 6, the Warrant Shares) at the Exercise Price during the Exercise Period. For the avoidance of doubt, the Warrant Holder shall not have any right to acquire ADSs.
(b) The Warrant Right shall be deemed granted subject to the Convertible Loan Agreement becoming effective pursuant to the terms thereof (such date hereinafter referred to as the Effective Date), with effect as of the Effective Date. If the Convertible Loan Agreement does not become effective pursuant to its terms, this Agreement and all rights and obligations of the Parties hereunder, with the exception of the provisions pursuant to Section 7, shall lapse, without any liability of one Party to the other Party.
(c) The Warrant may be exercised at any date and time between effective Disbursement pursuant to the terms of the Convertible Loan Agreement and the close of business on the third anniversary of the Effective Date (the Exercise Period).
(d) The Parties agree that the Company grants the Warrant Holder the Warrant Right as additional consideration for the Warrant Holder’s provision of financing under the terms of the Convertible Loan Agreement and accordingly, no additional consideration shall be due and payable by the Warrant Holder to the Company in respect of the grant of the Warrant Right hereunder.
Warrant Grant. At the Effective Time the Company shall grant to the Holder a warrant for the purchase of 100,000 common shares (the "Warrant Shares") of the Company, exercisable after the Effective Time until August 20, 2005, at a price of $1.50 per share.
Warrant Grant. The Company hereby agrees to issue to Consultant, or Consultant’s respective designee, a warrant in a form similar to that attached hereto (“Warrant”) purchase an aggregate of Six Hundred Seventy-Eight Thousand and Nine Hundred Sixty-Nine (678,969) shares of the Company’s common stock per share (the “Shares”), at an exercise price of $0.01 per share, of which 246,897 Shares shall vest and first become exercisable upon and subject to the Company’s full release of all liabilities and obligations under the presently existing line of credit issued to the Company by Wachovia Corporation. The Shares, when issued and paid for pursuant to the terms of the Warrant, shall be fully paid and non-assessable upon issuance and subject to the provisions of Section 3.2 below. The parties acknowledge that the Company intends to conduct a 6.172440476 for one reverse split shortly after the date of this Agreement. The parties further acknowledge and agree the Shares are a pre-split amount and that in the event the split ratio is lower than 6.172440476 for one (by way of example, 5 for one) than the number of Shares to be represented by the Warrant shall automatically be proportionately adjusted. The parties acknowledge that no adjustment shall be made to the Shares in the event that the split ratio exceeds 6.172440476 to one.
Warrant Grant. The Company shall issue Executive warrants to purchase a total of thirty million (30,000,000) shares of Company common stock at a $0.03/share exercise price, with such warrants exerciseable on a cashless basis and having a term of 5 years. The following is hereby added as Paragraph 9:
Warrant Grant. As a one-time consideration and as additional consideration for entering into this Agreement, the Company shall within thirty (30) days of the date of execution of this Agreement issue to Executive warrants to purchase 255,000 shares of the Company's common stock. The warrants shall be issued in three certificates with each certificate representing the right to acquire 85,000 shares of the Company's Common Stock. Warrants to acquire 85,000 shares of the Company's common stock shall vest immediately upon execution of this Agreement, with the warrants to acquire an additional 85,000 shares vesting on the first anniversary of the date of execution of this Agreement subject to the condition that Executive is employed by the Company at that time, and warrants to acquire the final 85,000 shares vesting on the second anniversary of the date of execution of this Agreement subject to the condition that Executive is employed by the Company at that time. This one time grant of warrants shall be effective as of the date of execution of this Agreement which shall be deemed the date of grant for all purposes and not as of the Effective Date. The warrants issued under this paragraph shall have an exercise price of $.01 per share, shall be exercisable for a period of ten (10) years from the date issued, and shall contain customary anti-dilution provisions. It is understood that the Board of Directors may from time to time in the future consider the grant of additional options or warrants to the Executive as additional compensation and incentive for future performance of his duties.
